Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

The expression of CCL2 by T lymphocytes of mammary tumor bearers: role of tumor-derived factors.

Owen JL, Lopez DM, Grosso JF, Guthrie KM, Herbert LM, Torroella-Kouri M, Iragavarapu-Charyulu V.

Cell Immunol. 2005 Jun;235(2):122-35. Epub 2005 Oct 21.

PMID:
16243300
2.

GM-CSF up-regulates the expression of CCL2 by T lymphocytes in mammary tumor-bearing mice.

Owen JL, Torroella-Kouri M, Handel-Fernandez ME, Iragavarapu-Charyulu V.

Int J Mol Med. 2007 Jul;20(1):129-36.

PMID:
17549399
3.

Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor.

Owen JL, Iragavarapu-Charyulu V, Gunja-Smith Z, Herbert LM, Grosso JF, Lopez DM.

J Immunol. 2003 Oct 15;171(8):4340-51.

4.

Impact of tumor-derived CCL2 on T cell effector function.

Vitiello PF, Shainheit MG, Allison EM, Adler EP, Kurt RA.

Immunol Lett. 2004 Feb 15;91(2-3):239-45.

PMID:
15019295
6.

Molecular events involved in the increased expression of matrix metalloproteinase-9 by T lymphocytes of mammary tumor-bearing mice.

Owen JL, Torroella-Kouri M, Iragavarapu-Charyulu V.

Int J Mol Med. 2008 Jan;21(1):125-34.

PMID:
18097625
7.
8.

Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.

Donkor MK, Lahue E, Hoke TA, Shafer LR, Coskun U, Solheim JC, Gulen D, Bishay J, Talmadge JE.

Int Immunopharmacol. 2009 Jul;9(7-8):937-48. doi: 10.1016/j.intimp.2009.03.021. Epub 2009 Apr 9.

PMID:
19362167
9.

MUC1/sec-expressing tumors are rejected in vivo by a T cell-dependent mechanism and secrete high levels of CCL2.

Grosso JF, Herbert LM, Owen JL, Lopez DM.

J Immunol. 2004 Aug 1;173(3):1721-30.

10.

In situ expression of IFN-gamma-inducible T cell alpha chemoattractant in breast cancer mounts an enhanced specific anti-tumor immunity which leads to tumor regression.

Chu Y, Yang X, Xu W, Wang Y, Guo Q, Xiong S.

Cancer Immunol Immunother. 2007 Oct;56(10):1539-49. Epub 2007 Feb 14.

PMID:
17659370
11.

Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice.

Abe F, Dafferner AJ, Donkor M, Westphal SN, Scholar EM, Solheim JC, Singh RK, Hoke TA, Talmadge JE.

Cancer Immunol Immunother. 2010 Jan;59(1):47-62. doi: 10.1007/s00262-009-0719-2. Epub 2009 May 18.

PMID:
19449184
13.

Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.

Li B, Lalani AS, Harding TC, Luan B, Koprivnikar K, Huan Tu G, Prell R, VanRoey MJ, Simmons AD, Jooss K.

Clin Cancer Res. 2006 Nov 15;12(22):6808-16.

14.

Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors.

DuPre' SA, Hunter KW Jr.

Exp Mol Pathol. 2007 Feb;82(1):12-24. Epub 2006 Aug 17.

PMID:
16919266
15.

Increased norepinephrine production associated with burn injuries results in CCL2 production and type 2 T cell generation.

Takahashi H, Tsuda Y, Kobayashi M, Herndon DN, Suzuki F.

Burns. 2004 Jun;30(4):317-21.

PMID:
15145188
16.

Regulation of FAS ligand expression by chemokine ligand 2 in human endometrial cells.

Selam B, Kayisli UA, Akbas GE, Basar M, Arici A.

Biol Reprod. 2006 Aug;75(2):203-9. Epub 2006 May 10.

PMID:
16687653
18.

Role of thymic stromal cell dysfunction in the thymic involution of mammary tumor-bearing mice.

Sun QL, Charyulu V, Lobo D, Lopez DM.

Anticancer Res. 2002 Jan-Feb;22(1A):91-6.

PMID:
12017339
19.

Involvement of CC chemokines in gammadelta T lymphocyte trafficking during allergic inflammation: the role of CCL2/CCR2 pathway.

Penido C, Costa MF, Souza MC, Costa KA, Candéa AL, Benjamim CF, Henriques Md.

Int Immunol. 2008 Jan;20(1):129-39. Epub 2007 Dec 4.

PMID:
18056919
20.

Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokines.

Winter H, van den Engel NK, Rüttinger D, Schmidt J, Schiller M, Poehlein CH, Löhe F, Fox BA, Jauch KW, Hatz RA, Hu HM.

J Transl Med. 2007 Nov 14;5:56.

Supplemental Content

Support Center